PUBLICATION
3‑Bromo‑5‑(ethoxymethyl)‑1,2‑benzenediol inhibits LPS-induced pro-inflammatory responses by preventing ROS production and downregulating NF-κB in vitro and in a zebrafish model
- Authors
- Ko, E.Y., Heo, S.J., Cho, S.H., Lee, W., Kim, S.Y., Yang, H.W., Ahn, G., Cha, S.H., Kwon, S.H., Jeong, M.S., Lee, K.P., Jeon, Y.J., Kim, K.N.
- ID
- ZDB-PUB-181212-26
- Date
- 2018
- Source
- International Immunopharmacology 67: 98-105 (Journal)
- Registered Authors
- Jeon, You-Jin
- Keywords
- Anti-inflammatory, BEMB, NF-?B, RAW264.7 cells, ROS, Zebrafish embryo
- MeSH Terms
-
- Rhodophyta/immunology
- Nitric Oxide Synthase Type II/genetics
- Nitric Oxide Synthase Type II/metabolism
- Disease Models, Animal
- Anti-Inflammatory Agents/therapeutic use*
- PubMed
- 30537636 Full text @ Int. Immunopharmacol.
Abstract
The anti-inflammatory effects of 3‑bromo‑5‑(ethoxymethyl)‑1,2‑benzenediol (BEMB) from Polysiphonia morrowii were evaluated in lipopolysaccharide (LPS)-induced RAW264.7 cells and zebrafish embryo. BEMB showed anti-inflammatory effects by inhibiting the production of nitric oxide (NO) and reactive oxygen species (ROS), and the expression of inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2) in the LPS-activated RAW264.7 cells and zebrafish embryo without cytotoxicity. Moreover, BEMB suppressed the protein and mRNA expression levels of nuclear factor (NF)-κB (p65 and inhibitor of NF-κB [IκB]-A) in RAW264.7 cells and zebrafish embryo, respectively. Collectively, the results of this study indicate that BEMB suppressed the production of pro-inflammatory mediators such as NO, iNOS, and COX-2 as well as their regulation in LPS-induced RAW264.7 cells and zebrafish embryos by inhibiting ROS production and NF-κB expression. Therefore, this study suggests that BEMB could be a potential anti-inflammatory agent for the treatment of inflammatory diseases.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping